Hormone therapies, such as selective estrogen receptor modulators, estrogenic receptor degraders, aromatase inhibitors and luteinizing hormone-releasing hormone (LHRH) agonists, have contributed significantly to decreasing breast cancer mortality [10]. The gene discussed is ESR1; the disease is breast carcinoma.